ABSTRACT
La vaccination contre la Covid-19 fait partie des mesures les plus efficaces pour réduire les formes graves et les décès dus au Sars-CoV-2. Pour améliorer l’accessibilité aux vaccins, les pharmaciens français ont été autorisés à les prescrire et les administrer en mars 2021. L’étude PharmaCoVax, qui vise à évaluer la satisfaction des usagers ayant bénéficié de ce service, a été menée dans les officines du 16 mars au 30 juin 2021.
ABSTRACT
Vaccination against Covid-19 is among the most effective measures to reduce severe forms and deaths from Sars-CoV-2. To improve accessibility to the vaccines, French pharmacists were authorized to prescribe and administer them in March 2021. The PharmaCoVax study, which aims to assess the satisfaction of users who have benefited from this service, was conducted in pharmacies from March 16 to June 30, 2021.
ABSTRACT
BACKGROUND: COVID-19 vaccines are among the most effective measures to reduce serious illness and death from infection with the highly contagious SARS-CoV-2 virus. To improve vaccine accessibility, pharmacists in France have been authorized to administer COVID-19 vaccinations since March 2021. This study aims to assess satisfaction among French people receiving their COVID-19 vaccination from a community pharmacist. METHODOLOGY: The PharmaCoVax study was conducted in French community pharmacies from 16 March to 30 June 2021. Interested pharmacists completed an online participation form, giving them access to the self-administered questionnaire. People receiving a pharmacist-administered COVID-19 vaccination completed this questionnaire in the pharmacy. RESULTS: Among the 442 pharmacists involved, 123 actively participated in the study. Overall, 5733 completed questionnaires were analyzed. A proportion of 59% (n = 3388) of those who received a pharmacist-administered COVID-19 vaccination had previously received their influenza vaccination, most often in the same pharmacy (n = 1744). Only 24% (n = 1370) of people visiting a pharmacy had tried to obtain their COVID-19 vaccination elsewhere. Satisfaction was excellent with a rating of 4.92 out of 5.00, and the net promoter score was 93. CONCLUSIONS: The pharmacist-administered COVID-19 vaccination service was overwhelmingly appreciated by users. The trust placed in pharmacists may explain the desire to have them perform additional vaccinations.
ABSTRACT
Vitamin D, which is increasingly in demand in pharmacies and increasingly prescribed, could be an asset in the treatment of Covid-19 by reducing mortality or the severity of the condition. Its potential immunomodulatory effect is currently being studied by numerous international teams of researchers.
ABSTRACT
Covigie is a free online platform set up in response to the COVID-19 global pandemic. It has enabled all caregivers and coordinators of primary care teams to report in real time the initiatives, observations, questions and problems encountered in the fight against the new coronavirus. The Covigie team summarised the information from the various contributions received, individual or collective, sent them to the health authorities and shared them with the caregivers.